Bone marrow angiogenesis in aplastic anemia - A study of CD 34 and VEGF expression in bone marrow biopsies

Hematology

Volumn 14, Issue 1, 2009, Pages 16-21

  Gupta, Parul ^a,c   Khurana, Nita ^a   Singh, Tejinder ^a   Gupta, Deepak ^b   Dhingra, Kajal Kiran ^a  

^a LOK NAYAK HOSPITAL   (India)

^b Sanjay Gandhi Hospital Mongol Puri   (India)

^c Paschim Vihar   (India)

Author keywords

Angiogenesis; Aplastic anemia; CD 34; Mean vascular density; VEGF

Indexed keywords

CD34 ANTIGEN; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANGIOGENESIS; ANTIGEN EXPRESSION; APLASTIC ANEMIA; ARTICLE; BONE MARROW; BONE MARROW APLASIA; BONE MARROW BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MEGAKARYOCYTE; MICROVASCULATURE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; BIOPSY; BIOSYNTHESIS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; VASCULARIZATION;

ANEMIA, APLASTIC; ANTIGENS, CD34; BIOPSY; BONE MARROW; HUMANS; IMMUNOHISTOCHEMISTRY; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 64949094793     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X385070     Document Type: Article

References (31)

1. Williams DM, Lynch RE, Cartwright GE. Prognostic factors in aplastic anemia. Clin Haematol 1978; 7: 467-474.
2. Camitta BM, Thomas ED, Nayhan DG, et al. A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 1979; 53: 504-514.
3. Gluckman E, Devergie A, Poros A, Degoulet P. Results of immunosuppression in 170 cases of severe aplastic anaemia. Br J Haematol 1982; 52: 541-550.
4. Sleijfer S, Lugtenburg PJ. AA: A review. Neth J Med 2003; 61(5): 157-163.
5. Kaufman DW, Kelly JP, Levy M, Shapiro S. The drug etiology of agranulocytosis and aplastic anemia. New York: Oxford University Press, 1991.
6. Brown KE, Young NS. Parvovirus B19 in human disease. Annu Rev Med 1997; 48: 59-67.
7. Bacigalupo A. Etiology of severe AA and outcome after allogeneic bone marrow transplantation or immunosuppressive therapy. Eur J Haematol 1996; 57: 16-19.
8. Marsh JCW, Chang J, Testa NG, Hows JM, Dexter TM. In vitro assessment of marrow 'stem cell' and stromal cell function in aplastic anaemia. Br J Haematol 1991; 78: 258-267.
9. Maciejewski JP, Hibbs JR, Anderson S, et al. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure. Exp Haematol 1994; 22: 1102-1110.
10. Selleri C, Sato T, Anderson S, Young NS, Maciejewski JP. Interferon γ and tumor necrosis factor a suppress both early and late stages of hematopoiesis and induce programmed cell death. J Cell Physiol 1995; 165: 538-546.
11. Wolk A, Simon-Stoos K, Nami I, et al. A mouse model of immunemediated AA. Blood 1998; 92(suppl): 639.
12. Calado RT, Garcia AB, Gallo DP, et al. P-glycoprotein function is impaired in CD34+ cells from patients with AA. Blood 2001; 98(suppl): 933.
13. Vulliamy T, Marrone A, Dokal I, Mason PJ. Association between AA and mutations in telomerase RNA. Lancet 2002; 359: 2168-2169
14. Holmberg LA, Seidel K, Leisenring W, Torok-Storb B: Aplastic anaemia: analysis of stromal cell function in long-term marrow cultures. Blood 1994; 84: 3685-3690.
15. Juneja HS, Gardner FH: Functionally abnormal marrow stromal cells in aplastic anaemia. Exp Hematol 1985; 13: 194-199
16. Pruneri G, Bertolini F, Soligo D, et al. Angiogenesis in myelodysplastic syndromes. Br J Cancer 1999; 81: 1398-1401.
17. Aguayo A, Kantarjian H, Manshouri T, et al. Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood 2000; 96: 2240-2245.
18. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815-821
19. Ghannadan M, Wimazal F, Simonitsch I, et al. Immunohistochemical detection of VEGF in the bone marrow of patients with acute myeloid leukemia (AML): Correlation between VEGF expression and the FAB category. Am J Clin Pathol 2003; 119: 663-671.
20. Krauth M, Simonitsch I, Aichberger K, et al. Immunohistochemical detection of VEGF in the bone marrow of patients with chronic myeloid leukemia and correlation with the phase of disease. Am J Clin Pathol 2004; 121: 473-481.
21. Mohle R, Green D, Moore MA, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 1997; 94: 663-668.
22. Rozman C, Marin P, Nomdedeu B, Montserrat E. Criteria for severe aplastic anaemia. Lancet 1987; 2: 955-957.
23. Camitta BM. What is the definition of cure for aplastic anaemia? Acta Haematol 2000; 103: 16-18.
24. Tuzuner N, Bennett JM. Reference standards for bone marrow cellularity. Leuk Res 1994; 18: 645-647.
25. Perez-Atayde AR, Sallan SE, Tedrow U, Connors S, Allred E, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia. Am J Pathol 1997; 150: 815-821
26. Gerber HP, Malik AK, Solar GP, et al. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature 2002; 417: 954-958.
27. Ji JL, Liu H, Sun C, Jiang SH, Ding RS. Expression of vascular endothelial growth factor in patients with aplastic anemia and its significance. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006; 14(2): 285-288.
28. Ji JL, Xu MY, Huang F, Liu H. Bone marrow angiogenesis in aplastic anemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2006; 14(1): 79-82.
29. Füreder W, Krauth MT, Sperr WR, et al. Evaluation of angiogenesis and vascular endothelial growth factor expression in the bone marrow of patients with aplastic anemia. Am J Pathol 2006; 168(1): 123-130.
30. Dutta P, Bhattacharya J, Karak AK, et al. Angiogenesis in myelodysplastic syndromes (MDS) in Indian patients. Indian J Pathol Microbiol 2006; 49(2): 218-20.
31. Leung EW, Rujkijyanont P, Beyene J, et al. Shwachman-Diamond syndrome: An inherited model of aplastic anemia with accelerated angiogenesis. Br J Haematol 2006; 133(5): 558-561.